Back to results
US 2010/0143498 A1Published application
Infusion solution for peripheral intravenous administration
AssigneeAjinomoto Co., Inc.
InventorsMutsuo SHIGETA, Kazuhiro ABIKO
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeAjinomoto Co., Inc.
InventorsMutsuo SHIGETA, Kazuhiro ABIKO
Estimating the term…
There is provided an infusion solution for peripheral intravenous administration comprising a multichamber vessel constructed in a connectable manner, which separately houses a sugar solution containing sugars, electrolytes and vitamin B1, and an amino acid solution containing amino acids, electrolytes and a sulfite, whereby the vitamin B1 and amino acids are stably maintained. In the infusion solution for peripheral intravenous administration, the sugar solution contains calcium gluconate, contains no greater than 1.4 g/L sodium lactate, has a pH of 4.0-4.7 and has a titratable acidity of 2-4, the amino acid solution contains 4.0-8.0 g/L sodium lactate, contains no calcium gluconate, has a pH of 6.8-7.2, contains free L-cysteine as cysteine and contains 0.05-0.2 g/L sodium hydrogen sulfite, and after the sugar solution and amino acid solution have been mixed, the infusion solution has a pH of 6.5-7.1 and a titratable acidity of 5-10.
An infusion solution for peripheral intravenous administration comprising a sugar solution containing sugars, a portion of electrolytes and vitamin B1, and an amino acid solution containing amino acids, a portion of electrolytes and a sulfite, separately housed in a multichamber vessel constructed in a connectable manner, wherein (1) the sugar solution contains calcium gluconate, contains no greater than 1.4 g/L sodium lactate, has a pH of 4.0-4.7 and has a titratable acidity of 2-4, (2) the amino acid solution contains 4-15 g/L sodium lactate, contains no calcium gluconate, has a pH of 6.8-7.2, contains free L-cysteine as cysteine and contains 0.05-0.2 g/L sodium hydrogen sulfite, and (3) after the sugar solution and amino acid solution have been mixed, the infusion solution for peripheral intravenous administration has an infusion pH of 6.5-7.1 and a titratable acidity of 5-10.
An infusion solution for peripheral intravenous administration comprising a sugar solution containing sugars, a portion of electrolytes and vitamin B1, and an amino acid solution containing amino acids, a portion of electrolytes and a sulfite, separately housed in a multichamber vessel with a connectable construction, wherein (1) the sugar solution contains calcium gluconate, contains no sodium lactate, has a pH of 4.0-4.5 and has a titratable acidity of 2-4, (2) the amino acid solution contains sodium lactate, contains no calcium gluconate, has a pH of 6.8-7.2, contains free L-cysteine as cysteine and contains 0.05-0.2 g/L sodium hydrogen sulfite, and (3) after the sugar solution and amino acid have been mixed, the infusion solution for peripheral intravenous administration has a pH of 6.5-7.1 and a titratable acidity of 5-10.
Dependencies are inferred from the claim text.